HEOR

News

ALK-Abello's Acarizax for dust mite allergy should soon be available through the NHS in England, Wales and Northern Ireland, but not in Scotland.

News

Oncopeptides hopes to reignite growth in multiple myeloma drug Pepaxti after getting reimbursement approval in Italy.

News

Santhera will launch its new drug for Duchenne muscular dystrophy in the UK within the next few weeks after getting the green light for NHS coverage.

News

NICE has said that four artificial intelligence technologies can be deployed by the NHS to detect fractures on X-rays in urgent care.

News

The money spent by the NHS on newly approved therapies recommended by NICE might have been better spent elsewhere, according to a new study.

News

Santhera's Duchenne muscular dystrophy (DMD) therapy Agamree has been cleared for NHS use after a confidential pricing agreement.